amben News
Most Popular amben Story
Amgen's D-mab emerged from early protein research
Fourteen years ago, Amgen's Scott Simonet developed five mouse lines that were engineered to overproduce a protein that flows throughout the body. He discovered that while the mice looked normal to... Read more...
Latest Headlines
- August 26, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
